{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:37:16Z","timestamp":1794854236066,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["K12AR084231"],"award-info":[{"award-number":["K12AR084231"]}]},{"name":"NIH","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1245\/s10434-025-17532-1","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:29:17Z","timestamp":1749194957000},"page":"8656-8667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes"],"prefix":"10.1245","volume":"32","author":[{"given":"Tori C.","family":"Nierenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri-Anne","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle A.","family":"DiLalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G. R.","family":"McDuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Kimmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-0558","authenticated-orcid":false,"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"17532_CR1","unstructured":"Breast Cancer Facts and Stats."},{"key":"17532_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/abs-21-89s","volume":"7","author":"Annelieke A Lemij","year":"2023","unstructured":"Lemij Annelieke A, Bastiaannet Esther, de Glas Nienke A, van den Bos Frederiek, Portielje Johanneke E. A, Liefers Gerrit-Jan, Derks Marloes G. M. Breast cancer in the older population: a global challenge\u2014an epidemiological perspective. Annals Breast Surg. 2023;7:17\u201317. https:\/\/doi.org\/10.21037\/abs-21-89s.","journal-title":"Annals Breast Surg"},{"issue":"1","key":"17532_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-020-05542-4","volume":"180","author":"JK Plichta","year":"2020","unstructured":"Plichta JK, Thomas SM, Vernon R, Fayanju OM, Rosenberger LH, Hyslop T, Hwang ES, Greenup RA. Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age. Breast Cancer Res Treat. 2020;180(1):227\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"17532_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jss.2020.04.036","volume":"254","author":"CE Marks","year":"2020","unstructured":"Marks CE, Ren Y, Rosenberger LH, Thomas SM, Greenup RA, Fayanju OM, McDuff S, Kimmick G, Shelley Hwang E, Plichta JK. Surgical management of the axilla in elderly women with node-positive breast cancer. J Surg Res. 2020;254:275\u201385.","journal-title":"J Surg Res"},{"issue":"11","key":"17532_CR5","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1245\/s10434-024-15812-w","volume":"31","author":"JC Dalton","year":"2024","unstructured":"Dalton JC, Crowell KA, Ntowe KW, van den Bruele AB, DiNome ML, Rosenberger LH, Thomas SM, Wang T, Hwang ES, Plichta JK. Utility of axillary staging in older patients with HER2-positive breast cancer. Ann Surg Oncol. 2024;31(11):7621\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"17532_CR6","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1245\/s10434-024-16106-x","volume":"31","author":"SM Record","year":"2024","unstructured":"Record SM, Thomas SM, Dalton J, van den Bruele AB, Chiba A, DiLalla G, DiNome ML, Rosenberger LH, Woriax HE, Hwang ES, et al. Triple-negative breast cancer in older patients: does SLNB guide therapy? Ann Surg Oncol. 2024;31(13):8802\u201312.","journal-title":"Ann Surg Oncol"},{"key":"17532_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jss.2024.01.037","volume":"296","author":"SM Record","year":"2024","unstructured":"Record SM, Thomas SM, Tian WM, van den Bruele AB, Chiba A, DiLalla G, DiNome ML, Kimmick G, Rosenberger LH, Woriax HE, et al. Anatomy versus biology: what guides chemotherapy decisions in older patients with breast cancer? J Surg Res. 2024;296:654\u201364.","journal-title":"J Surg Res"},{"issue":"10","key":"17532_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa040587","volume":"351","author":"KS Hughes","year":"2004","unstructured":"Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70\u00a0years of age or older with early breast cancer. N Engl J Med. 2004;351(10):971\u20137.","journal-title":"N Engl J Med"},{"issue":"3","key":"17532_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","volume":"16","author":"Ian H Kunkler","year":"2015","unstructured":"Kunkler Ian H, Williams Linda J, Jack Wilma J L, Cameron David A, Michael Dixon J. Breast-conserving surgery with or without irradiation in women aged 65\u00a0years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(14)71221-5.","journal-title":"Lancet Oncol"},{"issue":"8","key":"17532_CR10","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1245\/s10434-022-11728-5","volume":"29","author":"R Matar","year":"2022","unstructured":"Matar R, Sevilimedu V, Gemignani ML, Morrow M. Impact of endocrine therapy adherence on outcomes in elderly women with early-stage breast cancer undergoing lumpectomy without radiotherapy. Ann Surg Oncol. 2022;29(8):4753\u201360.","journal-title":"Ann Surg Oncol"},{"key":"17532_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1470-2045(24)00661-2","volume":"26","author":"MCDS Icro Meattini","year":"2025","unstructured":"Icro Meattini MCDS, Visani Luca, Scorsetti Marta, Fozza Alessandra, Meduri Bruno, De Rose Fiorenza, Bonzano Elisabetta, Prisco Agnese, Masiello Valeria, La Rocca Eliana, Spoto Ruggero, Becherini Carlotta. Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70\u00a0years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial. Lancet Oncol. 2025;26:37\u201350.","journal-title":"Lancet Oncol"},{"key":"17532_CR12","first-page":"1097","volume":"240","author":"B Elizabeth","year":"2025","unstructured":"Elizabeth B, Habermann CND, Palis Bryan E, Plichta Jennifer K, Wasif Nabil, Weigel Ronald J, Boughey Judy C. American college of surgeons cancer program annual report from 2021 participant user file. Am Coll Surg. 2025;240:1097.","journal-title":"Am Coll Surg"},{"key":"17532_CR13","doi-asserted-by":"publisher","first-page":"35525","DOI":"10.1002\/cncr.35525","volume":"131","author":"JK Plichta","year":"2024","unstructured":"Plichta JK, Thomas SM, Chanenchuk TC, Chan K, Hyslop T, Hwang ES, Greenup RA. Comparison of incident breast cancer cases in the largest national US tumor registries. Cancer. 2024;131:35525.","journal-title":"Cancer"},{"key":"17532_CR14","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1200\/JCO.2002.11.101","volume":"20","author":"JB Bernard Fisher","year":"2002","unstructured":"Bernard Fisher JB, Dignam James J, Lawrence Wickerham D, Mamounas Eleftherios P, Fisher Edwin R, Margolese Richard G, Nesbitt Lois, Paik Soonmyung, Pisansky Thomas M, Wolmark Norman. National surgical adjuvant breast and bowel project: tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141.","journal-title":"J Clin Oncol"},{"issue":"10","key":"17532_CR15","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1016\/j.ejca.2013.02.031","volume":"49","author":"RW Blamey","year":"2013","unstructured":"Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DAL, et al. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British association of surgical oncology (BASO) II trial. Eur J Cancer. 2013;49(10):2294\u2013302.","journal-title":"Eur J Cancer"},{"issue":"19","key":"17532_CR16","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"Kevin S Hughes","year":"2013","unstructured":"Hughes Kevin S, Schnaper Lauren A, Bellon Jennifer R, Cirrincione Constance T, Berry Donald A, McCormick Beryl, Muss Hyman B, Smith Barbara L, Hudis Clifford A, Winer Eric P, Wood William C. Lumpectomy plus tamoxifen with or without irradiation in women age 70\u00a0years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382\u20137. https:\/\/doi.org\/10.1200\/JCO.2012.45.2615.","journal-title":"J Clin Oncol"},{"issue":"1","key":"17532_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/curroncol30010032","volume":"30","author":"SGR McDuff","year":"2022","unstructured":"McDuff SGR, Blitzblau RC. Optimizing adjuvant treatment recommendations for older women with biologically favorable breast cancer: short-course radiation or long-course endocrine therapy? Curr Oncol. 2022;30(1):392\u2013400.","journal-title":"Curr Oncol"},{"key":"17532_CR18","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"RG Hongchao Pan","year":"2017","unstructured":"Hongchao Pan RG, Braybrooke Jeremy, Davies Christina, Taylor Carolyn, McGale Paul, Peto Richard, Pritchard Kathleen I, Bergh Jonas, Dowsett Mitch, Hayes Daniel F. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5\u00a0years. N Engl J Med. 2017;377:1836.","journal-title":"N Engl J Med"},{"issue":"5","key":"17532_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr3233","volume":"14","author":"M Lazzeroni","year":"2012","unstructured":"Lazzeroni M, Serrano D, Dunn BK, Heckman-Stoddard BM, Lee O, Khan S, Decensi A. Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. Breast Cancer Res. 2012;14(5):214.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"17532_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1186\/s12885-023-11291-6","volume":"23","author":"SH Kuo","year":"2023","unstructured":"Kuo SH, Tseng LM, Chen ST, Sagara Y, Chang YC, Yeh HT, Kuo YL, Hung CC, Lu TP, Lee YH, et al. Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). BMC Cancer. 2023;23(1):865.","journal-title":"BMC Cancer"},{"issue":"6","key":"17532_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.2000.18.6.1220","volume":"18","author":"Timothy J Whelan","year":"2000","unstructured":"Whelan Timothy J, Julian Jim, Wright Jim, Jadad Alejandro R, Levine Mark L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18(6):1220\u20139. https:\/\/doi.org\/10.1200\/JCO.2000.18.6.1220.","journal-title":"J Clin Oncol"},{"issue":"1","key":"17532_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-07112-w","volume":"203","author":"Lis Victoria Ravani","year":"2024","unstructured":"Ravani Lis Victoria, Calomeni Pedro, Wang Ming, Deng Daxuan, Speers Corey, Zaorsky Nicholas G, Shah Chirag. Comparison of partial-breast irradiation and intraoperative radiation to whole-breast irradiation in early-stage breast cancer patients: a Kaplan-Meier-derived patient data meta-analysis. Breast Cancer Res Treat. 2024;203(1):1\u201312. https:\/\/doi.org\/10.1007\/s10549-023-07112-w.","journal-title":"Breast Cancer Res Treat"},{"issue":"10237","key":"17532_CR23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, Chan C, Churn M, Cleator S, Coles CE, et al. Hypofractionated breast radiotherapy for 1\u00a0week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613\u201326.","journal-title":"Lancet"},{"issue":"11","key":"17532_CR24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1001\/jamaoncol.2017.1261","volume":"3","author":"Laura J Esserman","year":"2017","unstructured":"Esserman Laura J, Yau Christina, Thompson Carlie K, van Laura J, Veer T, Borowsky AD, Hoadley KA, Tobin NP, Nordenskj\u00f6ld B, Fornander T, St\u00e5l O, Benz CC, Lindstr\u00f6m LS. Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades. JAMA Oncol. 2017;3(11):1503. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1261.","journal-title":"JAMA Oncol"},{"issue":"1","key":"17532_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10549-022-06764-4","volume":"197","author":"JK Plichta","year":"2023","unstructured":"Plichta JK, Rushing CN, Lewis HC, Rooney MM, Blazer DG, Thomas SM, Hwang ES, Greenup RA. Implications of missing data on reported breast cancer mortality. Breast Cancer Res Treat. 2023;197(1):177\u201387.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"17532_CR26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1245\/s10434-024-16801-9","volume":"32","author":"K Chan","year":"2025","unstructured":"Chan K, Palis BE, Cotler JH, Janczewski LM, Zhu X, Boffa DJ, Park KU, Boughey JC, Plichta JK, In H, et al. Quality of cancer recurrence data in the national cancer database: a reappraisal of reporting readiness. Ann Surg Oncol. 2025;32(3):1553\u201364.","journal-title":"Ann Surg Oncol"},{"key":"17532_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.18.00118","volume":"3","author":"CD Jacobs","year":"2019","unstructured":"Jacobs CD, Carpenter DJ, Hong JC, Havrilesky LJ, Sosa JA, Chino JP. Radiation records in the national cancer database: variations in coding and\/or practice can significantly alter survival results. JCO Clin Cancer Inform. 2019;3:1\u20139.","journal-title":"JCO Clin Cancer Inform"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17532-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:40:54Z","timestamp":1760715654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17532-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["17532"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17532-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was in part supported by Duke Cancer Institute through NIH grant P30CA014236 (PI: Kastan) for the Biostatistics Core. The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. Plichta is supported by the National Institutes of Health Office of Women\u2019s Research Building Interdisciplinary Research Careers in Women\u2019s Health K12AR084231 (PI: Amundsen), as well as a recipient of research funding by the Color Foundation (PI: Plichta). J.P. is a member of Editorial Committee for the American Joint Committee on Cancer (AJCC), the Breast Panel for the AJCC, and the National Comprehensive Cancer Network (NCCN) Breast Cancer Diagnosis and Screening panel, as well as a member of the Editorial Board for Annals of Surgical Oncology. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}